ANO1 and cancer: On the other hand, although several inhibitors targeting ANO1 has been developed,[13, 22] their potential effectiveness against cancer remain unexplored yet by clinical trials because of the lack of strong preclinical evidence supporting ANO1's value as a promising therapeutic target in cancer.